ThinkEquity acted as sole book running manager for the offering.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INTS:
- Intensity Therapeutics announces common stock offering, no amount given
- Intensity Therapeutics reports data from Invincible-4 study
- Intensity Therapeutics Faces Nasdaq Delisting Notice
- Intensity Therapeutics price target lowered to $3.50 from $8.50 at Alliance Global Partners
- Intensity Therapeutics Faces Nasdaq Non-Compliance Notice